Sensorcaine Mpf NDC 63323-468

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-468Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0468Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-468-17	63323046817	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-468-17) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-468-01)Marketed from Nov 19, 2010
63323-468-37	63323046837	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-468-37) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-468-02)Marketed from Nov 19, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sensorcaine MpfSuffix: MPF
Generic name (nonproprietary): bupivacaine hydrochloride and epinephrine bitartrate
Active ingredients: Bupivacaine hydrochloride — 2.5 mg/mLEpinephrine bitartrate — .005 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration, Intracaudal, Perineural
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070966
Marketing start: Nov 19, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Amides (Chemical structure)Catecholamines (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 63323-468_cc1f6507-eb3e-4398-a1d3-0c56a2099e6bSPL ID cc1f6507-eb3e-4398-a1d3-0c56a2099e6bSPL set ID bc61a9a6-0a4e-48a9-b908-e5e66b9f23ebRxCUI 1012377, 1012384, 1012413, 1012417, 1724786, 1724787, 1724809, 1724810, 1867594, 1867596, 1867618, 1867620UNII 7TQO7W3VT8, 30Q7KI53AKUPC 0363323472030, 0363323461010, 0363323463014, 0363323468026, 0363323472016, 0363323468019
Pharmacologic class: Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N463323046817 followed by a unit qualifier and the quantity

Package 63323-0468-17. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

SENSORCAINE / SENSORCAINE WITH EPINEPHRINE is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of SENSORCAINE / SENSORCAINE WITH EPINEPHRINE are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see Dosage and Administration ( 2.2 )]. SENSORCAINE contains bupivacaine, an amide local anesthetic, and SENSORCAINE WITH EPINEPHRINE is a combination of bupivacaine, an amide local anesthetic, and epinephrine, an alpha and beta-adrenergic agonist. SENSORCAIN…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)